Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1971315 | 0.93 | OPRM1 (0.41) | DNM1OPRM1CA1 | |
| SCHEMBL7057450 | 0.91 | OPRM1 (0.39) | TSHRDNM1OPRM1 | |
| SCHEMBL1970569 | 0.87 | LMNA (0.37) | TSHR | |
| SCHEMBL8969121 | 0.84 | ALDH1A1 (0.33) | ALDH1A1TDP1TSHRDNM1SMN1; SMN2 | |
| SCHEMBL7099297 | 0.82 | DNM1 (0.41) | TSHRDNM1CA2OPRM1 | |
| SCHEMBL5985716 | 0.82 | — | — | |
| SCHEMBL17607505 | 0.81 | ALDH1A1 (0.34) | ALDH1A1TDP1TSHRDNM1SMN1; SMN2 | |
| SCHEMBL3358967 | 0.81 | ALDH1A1 (0.34) | ALDH1A1TDP1TSHRDNM1SMN1; SMN2 | |
| SCHEMBL3438064 | 0.80 | ALDH1A1 (0.37) | ALDH1A1TDP1TSHRDNM1SMN1; SMN2 | |
| SCHEMBL5985809 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578031-B2 | Dissymmetric N,N-dialkylamides used particularly for separating uranium(VI) from plutonium(IV), synthesis thereof and uses of same | COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÊNERGIES ALTERNATIVES (FR) | 2023-02-14 | — | — | US | disclosed |
| CN-110312702-B | Asymmetric N, N-dialkylamides, in particular for separating uranium (VI) and plutonium (IV), their synthesis and use | 原子能和替代能源委员会 | 2022-10-14 | — | — | CN | disclosed |
| US-20210332002-A1 | DISSYMMETRIC N,N-DIALKYLAMIDES USED PARTICULARLY FOR SEPARATING URANIUM(VI) FROM PLUTONIUM(IV), SYNTHESIS THEREOF AND USES OF SAME | ORANO CYCLE (FR) | 2021-10-28 | — | — | US | disclosed |
| EP-3194371-B1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY SCIENCE TECH & RES (SG) | 2020-09-02 | — | — | EP | disclosed |
| CN-107108518-B | Antibacterial imidazolium compounds | 新加坡科技研究局 | 2020-08-11 | — | — | CN | disclosed |
| CN-107922314-B | Novel asymmetric N, N-dialkyl amide and synthetic method and application thereof | 欧安诺循环 | 2020-07-07 | — | — | CN | disclosed |
| US-10570097-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-02-25 | — | — | US | disclosed |
| CN-110312702-A | Particularly for the asymmetric N of SEPARATION OF URANIUM (VI) and plutonium (IV), N- dialkyl amide, synthesis and purposes | 原子能和替代能源委员会 | 2019-10-08 | — | — | CN | disclosed |
| US-10252983-B2 | Dissymmetric N,N-dialkylamides, the synthesis thereof and uses of same | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2019-04-09 | — | — | US | disclosed |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-01-17 | — | — | US | disclosed |
| EP-3194371-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | Agency for Science, Technology and Research (SG) | 2017-07-26 | — | — | EP | disclosed |
| WO-2017017193-A1 | NOVEL DISSYMMETRIC N,N-DIALKYLAMIDES, THE SNYTHESIS THEREOF AND USES OF SAME | AREVA NC (FR) | 2017-02-02 | — | — | WO | disclosed |
| US-9469662-B2 | Process for preparing optically active biophosphinylalkanes | BASF SE (DE) | 2016-10-18 | — | — | US | disclosed |
| WO-2016043660-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-03-24 | — | — | WO | disclosed |
| CN-101253183-B | Process for preparing optically active diphosphanes | BASF SE | 2013-07-10 | — | — | CN | disclosed |
| EP-1913007-B1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2011-06-22 | — | — | EP | disclosed |
| US-20080242893-A1 | Process for Preparing Optically Active Diphosphanes | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
| CN-101253183-A | Process for preparing optically active diphosphanes | BASF SE (DE) | 2008-08-27 | — | — | CN | disclosed |
| EP-1913007-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007012655-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2007-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570097-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | ALDH1A1 3371/4885TDP1 4399/4885TSHR 3989/4885 |
| US-10252983-B2 | Dissymmetric N,N-dialkylamides, the synthesis thereof and uses of same | SMOX, DUOX2, NOS2 | ALDH1A1 1648/4885TDP1 1120/4885TSHR 4037/4885 |
| US-11578031-B2 | Dissymmetric N,N-dialkylamides used particularly for separating uranium(VI) from plutonium(IV), synthesis thereof and uses of same | NOS2, NOS1, NOS3 | ALDH1A1 1859/4885TDP1 841/4885TSHR 2439/4885 |
| US-20210332002-A1 | DISSYMMETRIC N,N-DIALKYLAMIDES USED PARTICULARLY FOR SEPARATING URANIUM(VI) FROM PLUTONIUM(IV), SYNTHESIS THEREOF AND USES OF SAME | NOS2, NOS1, NOS3 | ALDH1A1 1859/4885TDP1 841/4885TSHR 2439/4885 |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | ALDH1A1 3371/4885TDP1 4399/4885TSHR 3989/4885 |
| US-20080242893-A1 | Process for Preparing Optically Active Diphosphanes | PHOSPHO1, DCTPP1, DCPS | ALDH1A1 899/4885TDP1 4215/4885TSHR 4357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.